Comparative study of omega-3 fatty acid ethyl and icosapentate for dyslipidemia

Comparative study of omega-3 fatty acid ethyl and icosapentate for dyslipidemia - Comparative study of omega-3 fatty acid ethyl and icosapentate for dyslipidemia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000025227

Enrollment

Registered

2016-12-12

Start date

2013-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemia

Interventions

omega3 fatty acid ethyl 2000mg/day Icosapentoic acid1800mg/day

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Dyslipidemia Patients from whom informed consent was obtained

Exclusion criteria

Exclusion criteria: Patients from whom informed consent was not obtained

Design outcomes

Primary

Measure	Time frame
TG	—

Secondary

Measure	Time frame
1) T-cho, LDL, HDL 2) fatty acid fractionation 3) oxidized LDL 4) Lipo (A) 5) Remnant-Like Particle 6) MACE	—

Countries

Japan

Contacts

Public ContactAkira Sezai

Department of Cardiovascular Surgery Department of Cardiovascular Surgery

asezai@med.nihon-u.ac.jp03-3972-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026